{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:03:02Z","timestamp":1792166582765,"version":"4.4.0"},"reference-count":23,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2007,7,5]],"date-time":"2007-07-05T00:00:00Z","timestamp":1183593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2007,9]]},"abstract":"<jats:p><jats:bold>Summary.\u2002<\/jats:bold> We report on a series of 27 orthopaedic surgical procedures. It includes 20 radiosynoviortheses and seven major orthopaedic procedures, performed on 26 patients. The average age of patients was 36\u2003years (range: 8\u201353) and the average follow\u2010up time was 2.5\u2003years (range:1\u20135). There were 23 good results and four fair. In the synoviorthesis group (20 patients, 20 synoviortheses) the average age was 13.5\u2003years (range: 9\u201326) and the average follow\u2010up was 4.5\u2003years (range: 1\u20137). There were 19 good results and one fair. All synoviortheses were done with activated prothrombin complex concentrates (FEIBA), all the responses being good except in one case (which had the final fair result). The total dose of FEIBA used was 600\u2003IU\u2003kg<jats:sup>\u22121,<\/jats:sup> except in a patient that had a haemorrhagic complication. In fact, he required a prolongation of treatment up to a total dose of 2000\u2003IU\u2003kg<jats:sup>\u22121<\/jats:sup>. In the group of major orthopaedic procedures, the average age of the six patients was 30.5\u2003years (range: 11\u201353) and the average follow\u2010up was 2.5\u2003years (range: 1\u20135). There were six good results and one fair. Postoperative bleeding complications occurred in one of the seven major orthopaedic procedures performed (arterial pseudoaneurym after a total knee arthroplasty). Despite such complication, which had the final fair result, our study has shown that haemophilic patients with high inhibitor titres requiring orthopaedic surgery can undergo such procedures with a high expectation of success. In other words, orthopaedic surgery is now possible in haemophilia patients with high\u2010titre inhibitors, leading to an improved quality of life for these patients.<\/jats:p>","DOI":"10.1111\/j.1365-2516.2007.01520.x","type":"journal-article","created":{"date-parts":[[2007,7,5]],"date-time":"2007-07-05T14:34:53Z","timestamp":1183646093000},"page":"613-619","source":"Crossref","is-referenced-by-count":37,"title":["Orthopaedic surgery for inhibitor patients: a series of 27 procedures (25 patients)"],"prefix":"10.1111","volume":"13","author":[{"given":"E. C.","family":"RODRIGUEZ\u2010MERCHAN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"QUINTANA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"JIMENEZ\u2010YUSTE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"HERN\u00c1NDEZ\u2010NAVARRO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,7,5]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1996.tb01346.x"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V56.6.978.978"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V61.1.36.36"},{"key":"e_1_2_5_5_2","first-page":"626","article-title":"Transfusion","volume":"30","author":"Hilgartner M","year":"1990","journal-title":"Efficacy and safety of vapor-heated anti-inhibitor coagulant complex in hemophilia patients"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)90259-0"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-7963(93)70126-1"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-3886(98)00026-5"},{"issue":"1","key":"e_1_2_5_9_2","first-page":"S115","article-title":"Clinical experience with activated factor VII: focus on safety","volume":"9","author":"Roberts HR","year":"1998","journal-title":"Blood Coag Fibrinol"},{"key":"e_1_2_5_10_2","first-page":"141","article-title":"Treatment with a high titer anti\u2010factor VIII antibody by continuous factor VIII administration: report of a case","volume":"62","author":"White GC","year":"1983","journal-title":"Blood"},{"key":"e_1_2_5_11_2","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/archinte.1989.00390060103022","article-title":"The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII","volume":"149","author":"A Multicenter US experience","year":"1989","journal-title":"Arch Intern Med"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830210209"},{"issue":"1","key":"e_1_2_5_13_2","first-page":"10","article-title":"Use of porcine factor VIII for surgical procedures in haemophilia A patients with inhibitors","volume":"30","author":"Lozier JN","year":"1993","journal-title":"Sem Hematol"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(83)80032-8"},{"key":"e_1_2_5_15_2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/978-1-4471-1372-0","volume-title":"Diagnostic Imaging in Hemophilia","author":"Pettersson H","year":"1985"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1999.00036.x"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1999.00034.x"},{"key":"e_1_2_5_18_2","first-page":"154","article-title":"Recombinant factor VIIa in a multiple surgery (letter)","volume":"41","author":"Schulman S","year":"1994","journal-title":"Thromb Haemost"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)61340-8"},{"issue":"1","key":"e_1_2_5_20_2","first-page":"118","article-title":"Major surgery in haemophilic patients with inhibitors using recombinant factor VIIa","volume":"26","author":"Ingerslev J","year":"1996","journal-title":"Haemostasis"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1650292"},{"issue":"1","key":"e_1_2_5_22_2","first-page":"S97","article-title":"Experiences with continuous infusion of recombinant activated factor VII","volume":"9","author":"Schulman S","year":"1998","journal-title":"Blood Coag Fibrinol"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/9780470757260.ch27"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2003.00803.x"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2516.2007.01520.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2516.2007.01520.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T21:41:34Z","timestamp":1697233294000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2516.2007.01520.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["10.1111\/j.1365-2516.2007.01520.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2516.2007.01520.x","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,5]]}}}